Response and progression-free survival according to planned treatment duration in patients with relapsed multiple myeloma treated with carfilzomib, lenalidomide, and dexamethasone (KRd) versus…

Overview of attention for article published in Journal of Hematology & Oncology, April 2018

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#40 of 1,194)
High Attention Score compared to outputs of the same age (92nd percentile)
High Attention Score compared to outputs of the same age and source (99th percentile)

Mentioned by

news: 3 news outlets
blogs: 1 blog
policy: 1 policy source

twitter: 1 X user
wikipedia: 1 Wikipedia page

Citations

dimensions_citation: 34 Dimensions

Readers on

mendeley: 92 Mendeley

Summary News Blogs Policy documents X Wikipedia Dimensions citations

So far, Altmetric has seen 1 X post from an account with 66 followers.

#KRd is superior to #Rd in #MultipleMyeloma #cancer https://t.co/E4My5MNHqN

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.